Results 231 to 240 of about 114,925 (309)
Research on paclitaxel in chemotherapy-induced neuropathic pain: a bibliometric analysis integrating multiple databases. [PDF]
Zeng R +6 more
europepmc +1 more source
Body mass index and peripheral neuropathy across the glucose tolerance spectrum in Japanese adults
Graphical illustration of participant classification by metabolic status (normoglycemic, IGT, type 2 diabetes mellitus) and BMI with key neurological and metabolic assessments. In Japanese adults, obesity at the Japanese BMI threshold (≥25 kg/m2) is associated with adverse metabolic profiles across all glycemic states but exacerbates peripheral ...
Fukashi Ishibashi +6 more
wiley +1 more source
Sex differences in nerve injury-induced neuropathic pain via REST in primary sensory neurons. [PDF]
Tiwari A +12 more
europepmc +1 more source
ABSTRACT Background and Aims It is appreciated that current screening tools for diabetic peripheral neuropathy (DPN) often fail to detect early disease. Sudomotor (sweat gland) dysfunction, among the earliest manifestations of DPN, can be measured objectively by the SUDOSCAN® device. We compared SUDOSCAN® with conventional validated screening (Michigan
Rohan Shah +6 more
wiley +1 more source
Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician. [PDF]
Lawson E +12 more
europepmc +1 more source
Plasma Lipoproteins as Key Regulators in Neuropathic Pain: A Comprehensive Review of Mechanisms and Clinical Potential. [PDF]
Wei H +5 more
europepmc +1 more source
The first Australian guidance document on the assessment and management of idiopathic gastroparesis (IGP) reconceptualises IGP as a sensorimotor disorder. It proposes a novel multidisciplinary treatment algorithm and 20 high‐consensus recommendations, addressing common overlapping disorders, and providing clear guidance on associated disordered eating ...
Trina Kellar +11 more
wiley +1 more source
Microglia Polarization: A Key Regulatory Mechanism of Neuropathic Pain. [PDF]
Zhang T +7 more
europepmc +1 more source
ABSTRACT Background Little is known about substitution of alternative medications in the context of deprescribing. The objectives were to: (1) determine the frequency of medication substitutions among those who discontinued a central nervous system (CNS)‐active medication, and (2) characterize substitutions as potentially inappropriate (as per the 2023
Shelly L. Gray +6 more
wiley +1 more source

